RATIONALE: Neuropeptide Y (NPY) and its receptors are densely localized in brain regions involved in the mediation and modulation of fear, including the amygdala. Several studies showed that central NPY is involved in the modulation of fear and anxiety. OBJECTIVES: In the present study, we investigated (1) whether intra-amygdala injections of NPY affect the expression of conditioned fear and (2) whether NPY Y1 receptors (Y1R) mediates the effects of these intra-amygdaloid NPY injections. RESULTS: Intra-amygdala NPY injections robustly decreased the expression of conditioned fear measured by conditioned freezing and fear-potentiated startle. These NPY effects were not mimicked by intra-amygdala injections of the Y1R agonists Y-28 or Y-36, and co-infusion of the Y1R antagonist BIBO 3304 did not block the NPY effects. Furthermore, we tested Y1R-deficient mice in conditioned freezing and found no differences between wild type and mutant littermates. Finally, we injected NPY into the amygdala of Y1R-deficient mice. Y1R deficiency had no effect on the fear-reducing effects of intra-amygdala NPY. CONCLUSIONS: These data show an important role of the transmitter NPY within the amygdala for the expression of conditioned fear. Y1R do not appear to be involved in the mediation of the observed intra-amygdala NPY effects suggesting that these effects are mediated via other NPY receptors.
RATIONALE: Neuropeptide Y (NPY) and its receptors are densely localized in brain regions involved in the mediation and modulation of fear, including the amygdala. Several studies showed that central NPY is involved in the modulation of fear and anxiety. OBJECTIVES: In the present study, we investigated (1) whether intra-amygdala injections of NPY affect the expression of conditioned fear and (2) whether NPY Y1 receptors (Y1R) mediates the effects of these intra-amygdaloid NPY injections. RESULTS:Intra-amygdala NPY injections robustly decreased the expression of conditioned fear measured by conditioned freezing and fear-potentiated startle. These NPY effects were not mimicked by intra-amygdala injections of the Y1R agonists Y-28 or Y-36, and co-infusion of the Y1R antagonist BIBO 3304 did not block the NPY effects. Furthermore, we tested Y1R-deficient mice in conditioned freezing and found no differences between wild type and mutant littermates. Finally, we injected NPY into the amygdala of Y1R-deficient mice. Y1R deficiency had no effect on the fear-reducing effects of intra-amygdala NPY. CONCLUSIONS: These data show an important role of the transmitter NPY within the amygdala for the expression of conditioned fear. Y1R do not appear to be involved in the mediation of the observed intra-amygdala NPY effects suggesting that these effects are mediated via other NPY receptors.
Authors: Christian Grillon; Johanna M P Baas; Daniel S Pine; Shmuel Lissek; Megan Lawley; Valerie Ellis; Jessica Levine Journal: Biol Psychiatry Date: 2006-04-21 Impact factor: 13.382
Authors: Toshiro Kishi; Carl J Aschkenasi; Brian J Choi; Marisol E Lopez; Charlotte E Lee; Hongyan Liu; Anthony N Hollenberg; Jeffrey M Friedman; Joel K Elmquist Journal: J Comp Neurol Date: 2005-02-14 Impact factor: 3.215
Authors: Kiersten S Smith; Edward G Meloni; Karyn M Myers; Ashlee Van't Veer; William A Carlezon; Uwe Rudolph Journal: Psychopharmacology (Berl) Date: 2010-10-05 Impact factor: 4.530
Authors: M Bassi; N B Nakamura; W I Furuya; D S A Colombari; J V Menani; J M do Carmo; A A da Silva; J E Hall; E Colombari Journal: Acta Physiol (Oxf) Date: 2014-09-30 Impact factor: 6.311
Authors: Lauren L Vollmer; Sarah Schmeltzer; Jennifer Schurdak; Rebecca Ahlbrand; Jennifer Rush; Charles M Dolgas; Mark L Baccei; Renu Sah Journal: J Neurosci Date: 2016-01-27 Impact factor: 6.167